Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)

NCT02286063 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Lung; Disease, Fibroid (Chronic)

Interventions

DRUG: Ambulatory Oxygen

Sponsor

Royal Brompton & Harefield NHS Foundation Trust

Collaborators

[object Object]
[object Object]